MedTrace Logo

Impact of Vitamin B12 Supplementation With Iron and Folic Acid on Adolescent Girls

NCT01490944 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 360

Last updated 2012-02-28

No results posted yet for this study

Summary

The study is a clinical trial to assess the effectiveness of Vitamin B12 supplementation along with Iron Folic Acid (IFA) in combating anaemia. Adolescent anaemic girls will be randomly divided into two groups.

* Group 1: IFA weekly supplementation along with Information, Education, Communication sessions
* Group 2: IFA + Cyanocobalamin weekly supplementation along with Information, Education, Communication sessions

Duration of supplementation: 6 months

Conditions

  • Anaemia

Interventions

DRUG

Iron, Folic acid and Cyanocobalamin

Total duration= 6 months Iron=100 mg, Folic acid= 500 mcg, Cyanocobalamin 500 mcg weekly supplementation in the form of capsule for 6 weeks Iron=100 mg, Folic acid= 500 mcg, Cyanocobalamin 15 mcg weekly supplementation in the form of capsule for next 20 weeks

DRUG

Iron and Folic Acid

Iron= 100 mg, Folic acid= 500 mcg weekly supplementation in the form of capsule for 6 months

Sponsors & Collaborators

  • Delhi University

    collaborator OTHER

  • Indian Council of Medical Research

    lead OTHER_GOV

Principal Investigators

  • Dr. Gurdayal S Toteja, Ph.D · Indian Council of Medical Research

  • Priyanka Gupta, M.Sc · Indian Council of Medical Research

  • Dr. Neena Bhatia, Ph.D · Delhi University

  • Dr. Naval K Vikram, M.D. · All India Institute of Medical Sciences

  • Dr. Anupa Siddhu, Ph.D · Delhi University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
11 Years
Max Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2012-11-30
Completion
2013-01-31

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01490944 on ClinicalTrials.gov